CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,689,119 | +39.4% | 381,564 | +2.4% | 1.10% | +45.2% |
| Q2 2023 | $4,080,233 | +47.8% | 372,624 | +17.7% | 0.76% | +39.5% |
| Q1 2023 | $2,760,700 | -20.0% | 316,594 | -42.5% | 0.54% | -24.1% |
| Q4 2022 | $3,451,447 | +190.3% | 550,470 | +62.0% | 0.71% | +176.7% |
| Q3 2022 | $1,189,000 | -53.6% | 339,778 | -4.1% | 0.26% | -57.6% |
| Q3 2020 | $2,565,000 | +98.7% | 354,337 | +268.4% | 0.61% | +198.0% |
| Q2 2018 | $1,291,000 | -70.2% | 96,188 | -71.2% | 0.20% | -71.7% |
| Q1 2018 | $4,335,000 | +8.6% | 333,737 | -23.1% | 0.72% | +1.0% |
| Q4 2017 | $3,991,000 | -16.6% | 433,813 | -27.0% | 0.72% | +12.4% |
| Q3 2017 | $4,788,000 | – | 594,004 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |